InsiderTrades

Form 4 for STLN Starling Oncology, Inc.

Accepted 2025-11-20 00:00:00 ET · period of report 2025-11-18 · accession 0001213900-25-113113 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
M 2025-11-20 2025-11-18 STLN TOI M, LLC Dir J - Other — -2.49M 7.94M -24% —
I 2025-11-20 2025-11-18 STLN TOI M, LLC Dir J - Other — -590.9K 0 -100% —

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2025-11-18 J D 2,500,000 — 5,444,207 D — — (F1) On November 18, 2025, TOI M, LLC made a distribution in-kind of 590,892 shares of the Issuer's common stock to its members, including 11,818 shares distributed to M33 Growth I L.P. ("M33 LP"). Also on November 18, 2025, M33 LP made a distribution-in-kind of 2,500,000 shares of the Issuer's common stock to its limited partners. (F3) M33 Growth I GP LLC is the general partner of M33 LP and may be deemed to beneficially own the shares held by M33 LP but disclaims beneficial ownership of these shares except to the extent of its pecuniary interest therein.
2 Common Common Stock 2025-11-18 J D 590,892 — 0 I See Footnote — — (F1) On November 18, 2025, TOI M, LLC made a distribution in-kind of 590,892 shares of the Issuer's common stock to its members, including 11,818 shares distributed to M33 Growth I L.P. ("M33 LP"). Also on November 18, 2025, M33 LP made a distribution-in-kind of 2,500,000 shares of the Issuer's common stock to its limited partners. (F2) These securities were held by TOI M, LLC.
3 Common Common Stock 2025-11-18 J A 11,818 — 7,944,207 D — — (F1) On November 18, 2025, TOI M, LLC made a distribution in-kind of 590,892 shares of the Issuer's common stock to its members, including 11,818 shares distributed to M33 Growth I L.P. ("M33 LP"). Also on November 18, 2025, M33 LP made a distribution-in-kind of 2,500,000 shares of the Issuer's common stock to its limited partners. (F3) M33 Growth I GP LLC is the general partner of M33 LP and may be deemed to beneficially own the shares held by M33 LP but disclaims beneficial ownership of these shares except to the extent of its pecuniary interest therein.